Anti-inflammatory effects of targeted lung denervation in patients with COPD

Kistemaker Loes E.M., Slebos Dirk-Jan, Meurs Herman, Kerstjens Huib A.M., Gosens Reinoud

Source: Eur Respir J 2015; 46: 1489-1492
Journal Issue: November
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kistemaker Loes E.M., Slebos Dirk-Jan, Meurs Herman, Kerstjens Huib A.M., Gosens Reinoud. Anti-inflammatory effects of targeted lung denervation in patients with COPD. Eur Respir J 2015; 46: 1489-1492

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Additive effect of targeted lung denervation plus drug in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Targeted lung denervation: interventions in moderate COPD patients
Source: International Congress 2019 – Interventional pneumology: live out of the box round two
Year: 2019


Anti-inflammatory effects of targeted lung denervation in patients with COPD
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014

The effect of statin therapy in patients with chronic obstructive airway disease
Source: International Congress 2015 – COPD: notable points
Year: 2015


Long-term safety of bilateral targeted lung denervation in patients with COPD in a single procedure
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015


The effects of sildenafil on lung function in COPD
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Effects of Hochuekkito combined with pulmonary rehabilitation in patients with COPD
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017

Targeted lung denervation: COPD
Source: Virtual Congress 2020 – Bronchoscopic treatments for COPD and Emphysema
Year: 2020

The impact of insulin-sensitizers on lung function in COPD
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008


Two-year safety of targeted lung denervation in patients with moderate to severe COPD
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Effects of anti-inflammatory treatment on inflammatory infiltrate and ventilation parameters in patients with moderate COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 141s
Year: 2007

The influence of statin supplementation on inflammatory markers in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015

Effect of smoking on lung functions in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 157s
Year: 2005

Changes in the anti-inflammatory treatment of COPD
Source: Annual Congress 2012 - PG9 Progress on the treatment of COPD
Year: 2012


The therapeutic effects of zafirlukast on COPD induced pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 415s
Year: 2001

Effects of pulmonary rehabilitation on systemic inflammation in patients with advanced COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005

Low-dose amiodarone therapy may be responsible of serious adverse pulmonary effects in patients without pre-existing lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 280s
Year: 2004

Comparison of efficacy of respiratory rehabilitation in patients with COPD and interstitial lung disease
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011

Combination of beta2 agonists and anticholinergic drugs improves lung function in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 726s
Year: 2006

Pharmacological actions of statins: potential utility in COPD
Source: Eur Respir Rev 2009; 18: 222-232
Year: 2009